Concepedia

Publication | Open Access

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study

35

Citations

20

References

2021

Year

Abstract

These data support the use of D-Vd in Chinese patients with RRMM.

References

YearCitations

Page 1